| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $2,100,503 ) |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R37CA250661 | Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells | 000 | 5 | NIH | 1/26/2026 | $485,503 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 00 | 7 | CMS | 12/19/2025 | $1,615,000 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 02 | 6 | CMS | 10/16/2025 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI083671 | HMH Youth and Family TREE Program | 001 | 3 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI083671 | HMH Youth and Family TREE Program | 000 | 3 | SAMHSA | 1/13/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI084385 | I.C.A.R.E. - Integrated Care for Addiction Recovery Expansion | 001 | 5 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI084385 | I.C.A.R.E. - Integrated Care for Addiction Recovery Expansion | 000 | 5 | SAMHSA | 1/13/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM084539 | Hackensack Meridian Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (AIDE) | 000 | 5 | SAMHSA | 1/13/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM084539 | Hackensack Meridian Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (AIDE) | 001 | 5 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | UG3OD035546 | Enriching ECHO Cohorts with High-risk Pregnancies and Children with Disabilities (Enriching ECHO) | 000 | 2 | NIH | 11/18/2025 | $0 |
| | 2026 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA263662 | Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations | 000 | 4 | NIH | 1/15/2026 | $0 |
| | 2026 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI109025 | Critical Factors Influencing Echinocandin Resistance in Candida glabrata | 000 | 12 | NIH | 1/20/2026 | $0 |
| | 2026 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01DE028961 | Dissecting cell composition and drug sensitivity in human adenoid cystic carcinomas (ACCs) | 000 | 6 | NIH | 1/7/2026 | $0 |
| | 2026 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA239716 | Study of Interleukin 33 as a new immunotherapy of lung cancer | 000 | 6 | NIH | 2/13/2026 | $0 |
| | 2026 | 2023 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R00AI141622 | C5a/C5ar1 signaling in protective immunity during invasive candidiasis | 000 | 3 | NIH | 12/17/2025 | $0 |
| | 2026 | 2022 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA222090 | Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening | 000 | 6 | NIH | 1/14/2026 | $0 |
| | 2026 | 2022 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | CE146126 | Community Project Funding/Congressionally Directed Spending - Construction | 07 | 1 | HRSA | 12/10/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $35,559,283 ) (Continued on the next page) |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | T2554943 | Addiction Medicine Fellowship | 00 | 1 | HRSA | 7/1/2025 | $398,569 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI177342 | Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease | 000 | 3 | NIH | 5/28/2025 | $838,280 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI109025 | Critical Factors Influencing Echinocandin Resistance in Candida glabrata | 001 | 13 | NIH | 8/13/2025 | $2,558,055 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA263662 | Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations | 000 | 5 | NIH | 9/4/2025 | $1,368,048 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM084539 | Hackensack Meridian Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (AIDE) | 000 | 5 | SAMHSA | 9/16/2025 | $124,655 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI161013 | Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection | 000 | 5 | NIH | 8/13/2025 | $1,257,077 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI084385 | I.C.A.R.E. - Integrated Care for Addiction Recovery Expansion | 001 | 5 | SAMHSA | 9/14/2025 | $345,904 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI132374 | Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease | 001 | 8 | NIH | 4/11/2025 | $872,777 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI121080 | CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity | 000 | 9 | NIH | 7/22/2025 | $523,039 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI184502 | Shorter and more effective oral regimens for M. abscessus pulmonary disease | 000 | 1 | NIH | 1/21/2025 | $895,538 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI187349 | TLE transcription cofactors in anti-viral and anti-tumor immunity | 000 | 1 | NIH | 7/18/2025 | $3,436,588 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI182977 | Tissue specific immunity to fungal infections | 000 | 1 | NIH | 11/22/2024 | $857,215 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21AI187674 | C25-modified rifabutin analogs as a novel medicinal chemistry strategy to overcome drug-resistant tuberculosis | 000 | 1 | NIH | 11/13/2024 | $265,650 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 01 | 6 | CMS | 5/2/2025 | $0 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 00 | 6 | CMS | 12/16/2024 | $2,000,000 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA283566 | Nuclear envelope and predisposition to hepatic neoplasia | 001 | 4 | NIH | 7/21/2025 | $405,116 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA290808 | ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection | 000 | 2 | NIH | 4/8/2025 | $660,200 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | K22CA288932 | Cancer Misinformation and Use of Complementary and Alternative Therapy (CAM) among Patients with Cancer. | 004 | 2 | NIH | 8/27/2025 | $194,400 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | K00CA264409 | Optimizing adherence to lung cancer screening: Applying theory and implementation science to participant engagement | 000 | 5 | NIH | 9/3/2025 | $108,050 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R37CA250661 | Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells | 001 | 4 | NIH | 6/3/2025 | $53,945 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R37CA250661 | Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells | 000 | 4 | NIH | 1/7/2025 | $485,503 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | T2255323 | Dental Reimbursement Program | 00 | 1 | HRSA | 9/12/2025 | $153,079 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA254274 | Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy | 001 | 6 | NIH | 5/23/2025 | $40,110 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA254274 | Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy | 000 | 6 | NIH | 4/30/2025 | $361,003 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA270252 | Identifying and characterizing functional noncoding mutations in multiple myeloma | 001 | 3 | NIH | 5/22/2025 | $70,603 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA270252 | Identifying and characterizing functional noncoding mutations in multiple myeloma | 000 | 3 | NIH | 3/19/2025 | $635,423 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI141805 | Dissecting the molecular targets to overcome beta-lactam resistance in M. abscessus complex | 001 | 5 | NIH | 6/4/2025 | $901,706 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | U01AI187297 | Dissecting the host-plasmid interplay to unravel the spread of ESBL-producing K. pneumoniae | 000 | 1 | NIH | 8/11/2025 | $874,998 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01NS133233 | Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy. | 001 | 2 | NIH | 8/18/2025 | $44,275 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01NS133233 | Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy. | 000 | 2 | NIH | 2/20/2025 | $398,475 |
| | 2025 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI112579 | Tcf1 programs CD8 T cell responses to enhance viral and cancer immunity | 000 | 10 | NIH | 1/28/2025 | $624,855 |
|
